Cargando…

Barriers to routine G6PD testing prior to treatment with primaquine

BACKGROUND: Primaquine is essential for the radical cure of vivax malaria, however its broad application is hindered by the risk of drug-induced haemolysis in individuals with glucose-6-phosphate-dehydrogenase (G6PD) deficiency. Rapid diagnostic tests capable of diagnosing G6PD deficiency are now av...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ley, Benedikt, Thriemer, Kamala, Jaswal, Jessica, Poirot, Eugenie, Alam, Mohammad Shafiul, Phru, Ching Swe, Khan, Wasif Ali, Dysoley, Lek, Qi, Gao, Kheong, Chong Chee, Shamsudin, Ummi Kalthom, Chen, Ingrid, Hwang, Jimee, Gosling, Roly, Price, Ric N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553859/ https://www.ncbi.nlm.nih.gov/pubmed/28797255 http://dx.doi.org/10.1186/s12936-017-1981-y

Ejemplares similares

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

The challenges of introducing routine G6PD testing into radical cure: a workshop report
por: Ley, Benedikt, et al.
Publicado: (2015)

Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity
por: Alam, Mohammad Shafiul, et al.
Publicado: (2018)

G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study
por: Ley, Benedikt, et al.
Publicado: (2016)

Precarity at the Margins of Malaria Control in the Chittagong Hill Tracts in Bangladesh: A Mixed-Methods Study
por: Matin, Mohammad Abdul, et al.
Publicado: (2020)

An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
por: Chen, Ingrid, et al.
Publicado: (2015)

Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh
por: Ley, Benedikt, et al.
Publicado: (2020)

Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case–control data from Bangladesh
por: Ley, Benedikt, et al.
Publicado: (2021)

Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
por: Hamid, Muzamil Mahdi Abdel, et al.
Publicado: (2018)

Rationale for short course primaquine in Africa to interrupt malaria transmission
por: Eziefula, Alice C, et al.
Publicado: (2012)

Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
por: Ley, Benedikt, et al.
Publicado: (2022)

Pharmacovigilance for single low-dose primaquine: a practical approach
por: Poirot, Eugenie, et al.
Publicado: (2014)

Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh
por: Huwe, Tiffany, et al.
Publicado: (2022)

Molecular analysis demonstrates high prevalence of chloroquine resistance but no evidence of artemisinin resistance in Plasmodium falciparum in the Chittagong Hill Tracts of Bangladesh
por: Alam, Mohammad Shafiul, et al.
Publicado: (2017)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
por: Thriemer, Kamala, et al.
Publicado: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

A novel generation of hemozoin based malaria diagnostics show promising performance
por: Ley, Benedikt, et al.
Publicado: (2020)

A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh
por: Ley, Benedikt, et al.
Publicado: (2017)

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
por: Dysoley, Lek, et al.
Publicado: (2019)

Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study
por: Poirot, Eugenie, et al.
Publicado: (2016)

Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania
por: Mwaiswelo, Richard, et al.
Publicado: (2016)

Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2016)

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure
por: Thriemer, Kamala, et al.
Publicado: (2021)

Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
por: Ruwanpura, Varunika Sonani Hapuwatte, et al.
Publicado: (2021)

Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses
por: Yilma, Daniel, et al.
Publicado: (2023)

Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function
por: Douglas, Nicholas M., et al.
Publicado: (2023)

Methods for the field evaluation of quantitative G6PD diagnostics: a review
por: Ley, Benedikt, et al.
Publicado: (2017)

Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia
por: Adhikari, Bipin, et al.
Publicado: (2022)

Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study
por: Adhikari, Bipin, et al.
Publicado: (2023)

A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
por: Sadhewa, Arkasha, et al.
Publicado: (2023)

Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
por: Abreha, Tesfay, et al.
Publicado: (2017)

Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh
por: Engel, Nora, et al.
Publicado: (2021)

Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data
por: Stepniewska, Kasia, et al.
Publicado: (2022)

Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity
por: Chotsiri, Palang, et al.
Publicado: (2022)

Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
por: Abreha, Tesfay, et al.
Publicado: (2018)

Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine and Artesunate
por: Shekalaghe, Seif, et al.
Publicado: (2007)

Review of Mass Drug Administration for Malaria and Its Operational Challenges
por: Newby, Gretchen, et al.
Publicado: (2015)

The challenges in managing the growth of indigenous children in Perak State, Malaysia: A qualitative study
por: Chew, Chii-Chii, et al.
Publicado: (2022)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
por: Taylor, Walter R. J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jbjm0lkmgnbke0ofjtjto8gjlu